Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

59,552) 155,349

Operating income (loss) 13,247 72,273 85,520

Interest and other income

(expense), net (24,752) 300( c ) (24,452)

Income tax (benefit)

provision (4,696) 26,018(g) 21,322

Equity earnings of

unconsolidated entities,

net of tax 3,150 237(b) 3,387

Net (loss) income $(3,659) $46,792 $43,133

Preferred stock dividends $(5,393) $(5,393)

Net (loss) income

available to common

stockholders - basic $(9,052) $37,740

Net (loss) income per

common share

Basic $(0.12) $0.48

Diluted $(0.12)(h) $0.46(i)

Weighted average common

shares - basic 77,995 77,995

Weighted average common

shares - diluted 77,995(h) 83,169(i)

Three Months Ended September 30, 2007

Non-GAAP

Non-GAAP Adjusted Cash

GAAP Adjustments Basis(a)

Net revenue $237,636 $- $237,636

Cost of revenue 127,338 (13,938)(b)(d)(e) 113,400

Gross profit 110,298 13,938 124,236

Gross margin 46% 52%

Operating expenses:

Research and development 20,530 (1,535)(b)( c )(d) 18,995

Purchase of in-process

research and development 169,000 (169,000)(f) -

Selling, ge
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... Shandong Taibang Biological Products Co. Ltd., has received ... Food and Drug Administration (the "CFDA") for its ... in the Company,s public filings, the CFDA inspected ...
(Date:12/24/2014)... , December 23, 2014 ... Algeria , out today and available for free download ... actors driving change and growth in the sector today. ... scored notable successes has been in developing a homegrown pharmaceutical ... percent local production still remains some way off. A cursory ...
(Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
(Date:12/22/2014)... & Brussels (PRWEB) December 22, 2014 ... (CfPIE), the global leader of technical training across the ... for Clinical Data Management (SCDM) to provide the ... certification programs —providing access to the more than ... extends SCDM members with 10% off when registering for ...
Breaking Biology Technology:China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3
... users take advantage of the limitless minutes now included ... developed a device that can significantly improve the quality ... , ,"When you've been talking on a cell phone ... it gets," notes Zhenqiang "Jack" Ma, an assistant professor ...
... laboratory" of teaching technology will use Mediasite Live, ... Foundry, Inc. , to automatically record, distribute, archive ... , ,The laboratory, termed the Digital Union, is ... making informed investment decisions across Ohio's flagship campus ...
... Wisconsin Film Festival , waiting in line for tickets and ... of the process. However, thanks to the creation of a ... moviegoers will experience technological improvements previously unavailable. Designed by Madison-based ... , the system is designed to allow users to find ...
Cached Biology Technology:UW-Madison technology to advance cell phones 2UW-Madison technology to advance cell phones 3Ohio State's educational tech lab to use Sonic Foundry system 2Wisconsin Film Festival embraces new online ticket ordering system 2Wisconsin Film Festival embraces new online ticket ordering system 3
(Date:12/10/2014)... SAN DIEGO , Dec. 9, 2014 ... and collaboration catalyst that provides the connective tissue that ... by enabling them to easily share client-level information; earned ... Foundation to expand to organizations serving seniors aging in ... San Diego" partner on December 11 th 4-6p. ...
(Date:12/10/2014)...     Jifflenow ...   Jifflenow, a leading provider ... business-to-business (B2B) events, today announced a partnership with ... communication (NFC), Bluetooth low energy (BLE), and cloud-based ... Jifflenow will integrate its meeting scheduling ...
(Date:12/5/2014)...  Tute Genomics, a leader in cloud-based solutions for ... funding led by UK-based Eurovestech. Peak Ventures and a ... round. "We are at a pivotal time ... and seeks new approaches for the diagnosis, treatment and ... MBA, and CEO of Tute Genomics. "One of the ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... The Los Angeles World Airports (LAWA), which oversees airport ... contract modification to Unisys (NYSE: UIS ) to ... identify the 45,000 airport employees, contractors, police and others who ... is an early step in LAWA,s plan to move to ...
... CitiusTech announced today that its BI-Clinical platform for ... quality measures that are part of the ACO final ... BI-Clinical can now help ACO participants assess and ... domains - patient / caregiver experience, care coordination / ...
... Global HIV/AIDS prevention and treatment efforts are missing a ... countries by simply adding low-cost care for the many ... killing these same patients, according to a panel of ... the American Society of Tropical Medicine and Hygiene (ASTMH). ...
Cached Biology News:Los Angeles World Airports Selects Unisys to Upgrade ID Card Reader System and Network 2Los Angeles World Airports Selects Unisys to Upgrade ID Card Reader System and Network 3BI-Clinical Offers 100% Coverage of All ACO Quality Measures Released by CMS 2Tropical disease experts report missed opportunity to transform global HIV/AIDS fight 2Tropical disease experts report missed opportunity to transform global HIV/AIDS fight 3Tropical disease experts report missed opportunity to transform global HIV/AIDS fight 4
... Highly-purified, endotoxin-free plasmid DNA preparations are ... in quantities from 1mg to multi-gram ... as large-scale (100mg-multi-gram) preparations are made ... preparation is formulated according to customer ...
... Activins are polypeptide hormones which ... (TGF-) superfamily. The TGF- superfamily is ... factors which control many aspects of ... (1). Other members incude TGF-s, bone ...
... is a 96-well ELISA-compatible plate containing ... (mouse IgG 1 ) is directed ... (GST), and binds with high affinity ... in which the tag is exposed. ...
... AAIPharmas Routine Testing Laboratory (RTL) ... developed over 25 years. ,,Microbial method ... used to monitor the conditions of ... quality for manufactured products,,We offer a ...
Biology Products: